Endothelial nitric oxide synthase traffic inducer (NOSTRIN) is a negative regulator of disease aggressiveness in pancreatic cancer - Wang, Jian; Gaida, Matthias (Clinical cancer research, 2016)
Gesehen am 05.09.2017